Abstract
Background
Systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) are multisystemic autoimmune diseases with multifactorial nature. Considering the limitations of the current conventional serological tests for the diagnosis of these diseases, researchers strive to find more new valid biomarkers.
Methods
Sixty-nine patients with SLE, 63 patients with RA, and 71 healthy controls were recruited to evaluate the methylation level of interferon-induced protein 44-like (IFI44L) promoter. Quantitative methylation of the promoter region of the IFI44L gene was measured in extracted DNA of peripheral blood mononuclear cells (PBMCs) with methylation-quantification endonuclease-resistant DNA (MethyQESD) method.
Results
Our findings unveiled a drastic hypomethylation of IFI44L promoter in SLE and RA patients compared with healthy volunteers (mean: 40.23% ± 64.54%, 35.19% ± 24.09%, and 71.98% ± 23.83%, respectively; P < 0.001 for both SLE and RA). In comparison between SLE and RA patients with the control group, IFI44L promoter methylation had a sensitivity of 81.15% and 84.12%, respectively, and specificity was 76.05%. The promoter methylation level was not meaningfully different between SLE and RA patients (P = 0.267). Moreover, our analysis revealed that the methylation level of the IFI44L promoter was not significantly different between SLE disease activity and renal involvements (P > 0.05). While RA patients with a higher concentration of CRP had a lower DNA methylation level (P = 0.023).
Conclusion
The methylation level of IFI44L promoter was lower in PBMCs of Iranian patients with SLE and RA than that in the control group. Furthermore, DNA methylation level of the IFI44L promoter had a negative correlation with RA disease activity. However, there was not a significant association with the clinical characteristics of SLE.
Similar content being viewed by others
References
Kaul A et al (2016) Systemic lupus erythematosus. Nat Rev Dis Primers 2(1):16039
Demirkaya E et al (2020) New horizons in the genetic etiology of systemic lupus erythematosus and lupus-like disease: monogenic lupus and beyond. J Clin Med 9(3):712
Cassotta M, Pistollato F, Battino M (2020) Rheumatoid arthritis research in the 21st century: limitations of traditional models, new technologies, and opportunities for a human biology-based approach. ALTEX-Altern Anim Exp 37(2):223–242
Cojocaru M et al (2011) Manifestations of systemic lupus erythematosus. Maedica 6(4):330–336
Zucchi D et al (2019) One year in review 2019: systemic lupus erythematosus. Clin Exp Rheumatol 37(5):715–722
Crowson CS et al (2013) Rheumatoid arthritis and cardiovascular disease. Am Heart J 166(4):622-628.e1
Ngo ST, Steyn FJ, McCombe PA (2014) Gender differences in autoimmune disease. Front Neuroendocrinol 35(3):347–369
Svendsen AJ et al (2013) On the origin of rheumatoid arthritis: the impact of environment and genes—a population based twin study. PLoS One 8(2):e57304
Svendsen AJ et al (2013) On the origin of rheumatoid arthritis: the impact of environment and genes–a population based twin study. PLoS ONE 8(2):e57304–e57304
Aletaha D, Smolen JS (2018) Diagnosis and management of rheumatoid arthritis: a review. JAMA 320(13):1360–1372
Aringer M et al (2019) 2019 European league against rheumatism/american college of rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol 71(9):1400–1412
Yu C, Gershwin ME, Chang C (2014) Diagnostic criteria for systemic lupus erythematosus: a critical review. J Autoimmun 48:10–13
Lane SK, Gravel JW Jr (2002) Clinical utility of common serum rheumatologic tests. Am Fam Physician 65(6):1073
Aletaha D et al (2010) 2010 rheumatoid arthritis classification criteria: an American college of rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum 62(9):2569–2581
Aringer M et al (2019) Limited role of specificity of ANA for SLE classification. Response to:‘European league against rheumatism/American college of rheumatology classification criteria for systemic lupus erythematosus: the laboratory immunologist’s point of view’by Infantinol. Ann Rheum Dis 80:189
Bizzaro N et al (2012) Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis. Autoimmun Rev 12(2):97–106
Orr CK et al (2018) The utility and limitations of CRP, ESR and DAS28-CRP in appraising disease activity in rheumatoid arthritis. Front Med 5:185–185
Hedrich CM, Tsokos GC (2011) Epigenetic mechanisms in systemic lupus erythematosus and other autoimmune diseases. Trends Mol Med 17(12):714–724
Mazzone R et al (2019) The emerging role of epigenetics in human autoimmune disorders. Clin Epigenetics 11(1):34
Wright HL et al (2017) Low-density granulocytes: functionally distinct, immature neutrophils in rheumatoid arthritis with altered properties and defective TNF signalling. J Leukoc Biol 101(2):599–611
Rodríguez-Carrio J et al (2019) IRF4 and IRGs delineate clinically relevant gene expression signatures in systemic lupus erythematosus and rheumatoid arthritis. Front Immunol 9:3085
Karimifar M et al (2019) Interferon-induced protein 44-like gene promoter is differentially methylated in peripheral blood mononuclear cells of systemic lupus erythematosus patients. J Res Med Sci. https://doi.org/10.4103/jrms.JRMS_83_19
Chen S et al (2019) Genome-wide DNA methylation profiles reveal common epigenetic patterns of interferon-related genes in multiple autoimmune diseases. Front Genet 10:223
Zhang B et al (2020) A simple and highly efficient method of IFI44L methylation detection for the diagnosis of systemic lupus erythematosus. Clin Immunol 221:108612
Zhao M et al (2016) IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus. Ann Rheum Dis 75(11):1998–2006
Fuss IJ et al (2009) Isolation of whole mononuclear cells from peripheral blood and cord blood. Curr Protoc Immunol 85(1):711–718
Bettstetter M et al (2008) MethyQESD, a robust and fast method for quantitative methylation analyses in HNPCC diagnostics using formalin-fixed and paraffin-embedded tissue samples. Lab Invest 88(12):1367–1375
Luo S, Zhao M, Lu Q (2016) LB760 Upregulation of IFI44L induces inflammation by activating TBK1/IRF3 pathway in systemic lupus erythematosus. J Investig Dermatol 136(8):B2
DeDiego ML, Martinez-Sobrido L, Topham DJ (2019) Novel functions of IFI44L as a feedback regulator of host antiviral responses. J Virol. https://doi.org/10.1128/JVI.01159-19
Busse DC et al (2020) Interferon-induced protein 44 and interferon-induced protein 44-like restrict replication of respiratory syncytial virus. J Virol. https://doi.org/10.1128/JVI.00297-20
Kyogoku C et al (2013) Cell-specific type I IFN signatures in autoimmunity and viral infection: what makes the difference? PLoS ONE 8(12):e83776–e83776
Zhu H et al (2019) Rheumatoid arthritis–associated DNA methylation sites in peripheral blood mononuclear cells. Ann Rheum Dis 78(1):36–42
Bagheri H et al (2020) TFPI2 and NDRG4 gene promoter methylation analysis in peripheral blood mononuclear cells are novel epigenetic noninvasive biomarkers for colorectal cancer diagnosis. J Gene Med 22(8):e3189
von Rosenstiel C et al (2020) Correlation of the quantitative level of MGMT promoter methylation and overall survival in primary diagnosed glioblastomas using the quantitative MethyQESD method. J Clin Pathol 73(2):112–115
Tanaka K, Okamoto A (2007) Degradation of DNA by bisulfite treatment. Bioorg Med Chem Lett 17(7):1912–1915
Rajput SK et al (2012) An improved method of bisulfite treatment and purification to study precise DNA methylation from as little as 10 pg DNA. Appl Biochem Biotechnol 168(4):797–804
Coit P et al (2013) Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naïve CD4+ T cells from lupus patients. J Autoimmun 43:78–84
Coit P et al (2015) Epigenome profiling reveals significant DNA demethylation of interferon signature genes in lupus neutrophils. J Autoimmun 58:59–66
Coit P et al (2015) Renal involvement in lupus is characterized by unique DNA methylation changes in naïve CD4+ T cells. J Autoimmun 61:29–35
Acknowledgements
We would like to appreciate the financial support provided by Isfahan University of Medical Sciences.
Author information
Authors and Affiliations
Contributions
All authors were involved in whole work and the manuscript has been seen and approved by all the authors.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest.
Ethical approval
This study was approved by the ethics committee of Isfahan university of medical sciences.
Informed consent
Informed consent was obtained from all subjects. Also, all authors are agree to publish this manuscript in your valuable journal.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Salesi, M., Dehabadi, M.H., Salehi, R. et al. Differentially methylation of IFI44L gene promoter in Iranian patients with systemic lupus erythematosus and rheumatoid arthritis. Mol Biol Rep 49, 3065–3072 (2022). https://doi.org/10.1007/s11033-022-07134-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-022-07134-5